Li Zhang
- Molecular mechanism of lung aging in senescence-accelerated mouse (SAM)By Yiming Yuan, Xiuying Hu, Li Luo, Ming Yang, Zhiguang Su and Xiaoyan ZhangYiming Yuan1Department of Geriatrics, West China Hospital,Sichuan Universtiy, Chengdu, ChinaXiuying Hu1Department of Geriatrics, West China Hospital,Sichuan Universtiy, Chengdu, ChinaLi Luo1Department of Geriatrics, West China Hospital,Sichuan Universtiy, Chengdu, ChinaMing Yang1Department of Geriatrics, West China Hospital,Sichuan Universtiy, Chengdu, ChinaZhiguang Su2Cardiovascular Research Section I, West China Hospital,Sichuan Universtiy, Chengdu, ChinaXiaoyan Zhang1Department of Geriatrics, West China Hospital,Sichuan Universtiy, Chengdu, China
- Late-breaking abstract: The Guangzhou COPD exacerbation study: Relationship of exacerbations with viral infections and soluble biomarkersBy Christopher McCrae, Yumin Zhou, Jin Qian, Jenny Xia, Christina Wang, Marleen van Geest, Renhong Tang, Li Zheng, Changting Liu, Anna Nilsson, Meizhuo Zhang, Ziad Taib, Jinping Zheng, Piet Bruijnzeel, Yi Gu, Rongchang Chen and Nanshan ZhongChristopher McCrae1Respiratory, Inflammation & Autoimmunity (RIA) Innovative Medicines Unit, AstraZeneca R&D Mölndal, Mölndal, SwedenYumin Zhou2Guangzhou Institute of Respiratory Disease, Guangzhou Medical University, Guangzhou, ChinaJin Qian3Asia & Emerging Markets Innovative Medicines Unit, AstraZeneca R&D Shanghai, Shanghai, ChinaJenny Xia3Asia & Emerging Markets Innovative Medicines Unit, AstraZeneca R&D Shanghai, Shanghai, ChinaChristina Wang3Asia & Emerging Markets Innovative Medicines Unit, AstraZeneca R&D Shanghai, Shanghai, ChinaMarleen van Geest1Respiratory, Inflammation & Autoimmunity (RIA) Innovative Medicines Unit, AstraZeneca R&D Mölndal, Mölndal, SwedenRenhong Tang3Asia & Emerging Markets Innovative Medicines Unit, AstraZeneca R&D Shanghai, Shanghai, ChinaLi Zheng3Asia & Emerging Markets Innovative Medicines Unit, AstraZeneca R&D Shanghai, Shanghai, ChinaChangting Liu3Asia & Emerging Markets Innovative Medicines Unit, AstraZeneca R&D Shanghai, Shanghai, ChinaAnna Nilsson1Respiratory, Inflammation & Autoimmunity (RIA) Innovative Medicines Unit, AstraZeneca R&D Mölndal, Mölndal, SwedenMeizhuo Zhang3Asia & Emerging Markets Innovative Medicines Unit, AstraZeneca R&D Shanghai, Shanghai, ChinaZiad Taib1Respiratory, Inflammation & Autoimmunity (RIA) Innovative Medicines Unit, AstraZeneca R&D Mölndal, Mölndal, SwedenJinping Zheng2Guangzhou Institute of Respiratory Disease, Guangzhou Medical University, Guangzhou, ChinaPiet Bruijnzeel1Respiratory, Inflammation & Autoimmunity (RIA) Innovative Medicines Unit, AstraZeneca R&D Mölndal, Mölndal, SwedenYi Gu3Asia & Emerging Markets Innovative Medicines Unit, AstraZeneca R&D Shanghai, Shanghai, ChinaRongchang Chen2Guangzhou Institute of Respiratory Disease, Guangzhou Medical University, Guangzhou, ChinaNanshan Zhong2Guangzhou Institute of Respiratory Disease, Guangzhou Medical University, Guangzhou, China
- Late-breaking abstract: EGFR specific single chain antibody deliver siRNAs restore gefitinib sensitivity in resistant NSCLC cellsBy Yuan Lu, Li Liu, Rui Zhang and Xinling RenYuan Lu1Department of Respiratory, Xijing Hospital of Fourth Military Medical University, Xi'an, Shaan'xi, ChinaLi Liu1Department of Respiratory, Xijing Hospital of Fourth Military Medical University, Xi'an, Shaan'xi, ChinaRui Zhang2The State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, Shaan'xi, ChinaXinling Ren1Department of Respiratory, Xijing Hospital of Fourth Military Medical University, Xi'an, Shaan'xi, China
- Late-breaking abstract: Clinical epidemiology of lung cancer in China: A retrospective study of 4205 patientsBy Lei Li, Weimin Li, Li Zhang and Dan LiuLei Li1Department of Respiratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, ChinaWeimin Li1Department of Respiratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, ChinaLi Zhang1Department of Respiratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, ChinaDan Liu1Department of Respiratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China
- Does small-airways dysfunction predispose to greater perceived respiratory symptoms during bronchoconstriction in asthma?By Li Hong-Lin, Hong Ping Zhang, Bing Miao Liang and Gang WangLi Hong-Lin1Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, ChinaHong Ping Zhang1Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, ChinaBing Miao Liang2Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, ChinaGang Wang1Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, China
- Effects of hydrogen sulfide on ozone-induced features of chronic obstructive pulmonary diseaseBy Feng Li, Pengyu Zhang, Min Zhang, Li Liang, Xiaoyuan Sun, Aihua Bao, Min Li, Yueqin Tang, Jicheng Gong, Jim (Junfeng) Zhang, Ian Adcock, Kian Fan Chung and Xin ZhouFeng Li1Dept of Respiratory Medicine, Shanghai First People Hospital, Shanghai Jiaotong University, Shanghai, ChinaPengyu Zhang1Dept of Respiratory Medicine, Shanghai First People Hospital, Shanghai Jiaotong University, Shanghai, ChinaMin Zhang1Dept of Respiratory Medicine, Shanghai First People Hospital, Shanghai Jiaotong University, Shanghai, ChinaLi Liang3Dept of Respiratory Medicine, Shanghai Third People Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, ChinaXiaoyuan Sun1Dept of Respiratory Medicine, Shanghai First People Hospital, Shanghai Jiaotong University, Shanghai, ChinaAihua Bao1Dept of Respiratory Medicine, Shanghai First People Hospital, Shanghai Jiaotong University, Shanghai, ChinaMin Li1Dept of Respiratory Medicine, Shanghai First People Hospital, Shanghai Jiaotong University, Shanghai, ChinaYueqin Tang1Dept of Respiratory Medicine, Shanghai First People Hospital, Shanghai Jiaotong University, Shanghai, ChinaJicheng Gong4Division of Environmental Sciences & Policy, Duke University, Durham, United StatesJim (Junfeng) Zhang4Division of Environmental Sciences & Policy, Duke University, Durham, United StatesIan Adcock5Airway Diseases Section, National Heart and Lung Institute, Imperial College London, London, United KingdomKian Fan Chung5Airway Diseases Section, National Heart and Lung Institute, Imperial College London, London, United KingdomXin Zhou1Dept of Respiratory Medicine, Shanghai First People Hospital, Shanghai Jiaotong University, Shanghai, China
- Surface-bound TIMP-1 on PMNs promotes pericellular proteolysis: A new culprit in COPD?By Francesca Polverino, Li Zhang, Maria Laucho-Contreras and Caroline OwenFrancesca Polverino1Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, United States2Pulmonary, Lovelace Respiratory Research Institute, Albuquerque, United States3Pulmonary, University of Parma, Parma, ItalyLi Zhang1Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, United StatesMaria Laucho-Contreras1Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, United StatesCaroline Owen1Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, United States2Pulmonary, Lovelace Respiratory Research Institute, Albuquerque, United States
- Commuting mode and pulmonary function in Shanghai, ChinaBy Adam W. Gaffney, Jing-qing Hang, Mi-Sun Lee, Li Su, Feng-ying Zhang and David C. ChristianiArticle | Published in 2015 in European Respiratory JournalAdam W. Gaffney1Massachusetts General Hospital, Boston, MA, USAJing-qing Hang2Shanghai Putuo District People's Hospital, Shanghai, ChinaMi-Sun Lee3Environmental and Occupational Medicine and Epidemiology Program, Dept of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USALi Su3Environmental and Occupational Medicine and Epidemiology Program, Dept of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USAFeng-ying Zhang2Shanghai Putuo District People's Hospital, Shanghai, ChinaDavid C. Christiani1Massachusetts General Hospital, Boston, MA, USA3Environmental and Occupational Medicine and Epidemiology Program, Dept of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA4Harvard Medical School, Boston, MA, USA
- Commuting mode and pulmonary function in Shanghai, ChinaBy Adam W. Gaffney, Jing-qing Hang, Mi-Sun Lee, Li Su, Feng-ying Zhang and David C. ChristianiAdam W. Gaffney1Massachusetts General Hospital, Boston, MA, USAJing-qing Hang2Shanghai Putuo District People's Hospital, Shanghai, ChinaMi-Sun Lee3Environmental and Occupational Medicine and Epidemiology Program, Dept of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USALi Su3Environmental and Occupational Medicine and Epidemiology Program, Dept of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USAFeng-ying Zhang2Shanghai Putuo District People's Hospital, Shanghai, ChinaDavid C. Christiani1Massachusetts General Hospital, Boston, MA, USA3Environmental and Occupational Medicine and Epidemiology Program, Dept of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA4Harvard Medical School, Boston, MA, USA
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.